CMSC: Natalizumab for MS During the Covid-19 Pandemic
Overall outcomes good after Covid infection, vaccine for most patients At the recent Consortium of...
Read More
CMSC 2021
CMSC: Real-World Study Confirms Dimethyl Fumarate Safety
GI disorders most common reason for Tx discontinuation Safety is always a concern for any...
Read More
CMSC: Most MS Providers Think Diroximel Fumarate Has Better GI Profile
Prescribers cite tolerability when switching from other DMTs For those who doubt the effectiveness...
Read More
CMSC 2021: A Focus on Multiple Sclerosis eBook
Focus on Multiple Sclerosis CMSC eBook
Read More